Wockhardt Q3 Result 2024: Date and Time, Share Price and Target

News: Wockhardt, a name synonymous with excellence in healthcare, has been making significant strides in the pharmaceutical and biotechnology industry. Let’s delve into the fascinating world of Wockhardt and explore its journey, achievements, and impact.

Date and Time of Announcement

Wockhardt, the pharmaceutical company, is all set to reveal its financial performance for the third quarter of 2024. The eagerly awaited announcement is scheduled for  on a specific date and time. Investors, analysts, and stakeholders are keen to know how the company has fared during this period.

Share Price Movement

The share price of Wockhardt (NSE:WOCKPHARMA) has been closely watched by market participants. As of the most recent data, the stock is trading at Rs. 458.55. However, it’s essential to understand that share prices can fluctuate due to various factors, including market sentiment, company performance, and industry trends.

Target and Analysis

Share Price Target

Market experts have their eyes on Wockhardt’s share price target. While it’s challenging to predict with absolute certainty, some projections indicate that the initial price could be around Rs. 480. Additionally, there’s a second target of Rs. 500, which aligns with budget expectations.

Fundamental Analysis

Wockhardt falls under the pharmaceutical segment industry, specializing in the pharmaceuticals vertical. Its market capitalization stands at approximately Rs. 4,361.1 crore. The company has declared an equity dividend of Rs. 0 per share in the past year, resulting in a dividend yield of 0% at the current share price.

Quality and Valuation

• Quality: Wockhardt’s performance in terms of earnings and profit margins is uncertain, with an EPS of –. The book value per share today is Rs. 121.64.
• Valuation: The stock’s valuation is currently unclear, which means it’s a bit confusing for investors. The delivery percentage (47.14%) indicates that many investors anticipate a positive price movement.

Investor Decision

Whether to BUY or SELL Wockhardt shares depends on individual risk appetite and the risk-reward ratio. Analysts provide the following guidance:

• STRONG BUY: Consider buying if all indicators are green.
• BUY (at Lower Levels): Buy when at least two indicators are green.
• NEUTRAL or HOLD (With Stop Loss): Hold if only one indicator is green.
• SELL (if NO Green Indicator): Be cautious if no indicators are green.

About Wockhardt :

Founding and Growth

Founded in 1967, Wockhardt has evolved into India’s leading research-based global healthcare enterprise. Its diverse portfolio spans Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs), and Super Speciality Hospitals. Dr. Habil Khorakiwala, the visionary behind Wockhardt, set the stage for a remarkable journey.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

Areas of Expertise

1. Pharmaceuticals: Wockhardt produces formulations, biopharmaceuticals, nutrition products, vaccines, and APIs. With manufacturing plants in India, the UK, Ireland, France, and the US, it caters to a global audience.
2. Biotechnology: Wockhardt’s commitment to cutting-edge research drives breakthroughs in biotechnology. It aims to enhance lives through innovative solutions.
3. Super Speciality Hospitals: Beyond medicines, Wockhardt operates a chain of advanced super speciality hospitals. These centers provide top-notch healthcare services across various disciplines.

Global Footprint

Wockhardt’s impact extends beyond India. It boasts subsidiaries in the US, UK, Ireland, and France. The company’s novel New Chemical Entities (NCEs) have garnered attention globally. Notably, Emrok and Emrok O, India’s first research-patented drugs for treating multidrug-resistant Gram Positive Infections, have transformed lives.

Research Wins, Life Wins

Wockhardt’s commitment to research and development is unwavering. It continues to explore new frontiers, develop life-saving drugs, and contribute to global health.

In a world where health challenges are ever-evolving, Wockhardt stands tall—a beacon of hope and healing.

Keep an eye on Wockhardt’s Q3 results announcement, and make informed decisions based on your investment strategy. Remember that the stock market can be unpredictable, so thorough research and understanding are crucial.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.